Patient Guide: A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases

We'll Help You Connect with This Trial

Quri.ai is a free clinical trial matching service. We help patients like you connect directly with research sites conducting this study.

  • ✓ Get matched to the right study location for you
  • ✓ Connect directly with study coordinators at 28 participating sites
  • ✓ Understand eligibility with our simplified screening tool
  • ✓ Free service - we're here to help you access clinical research
Trial ID: NCTNCT07115745
Status: 🟢 Enrolling Now
Condition: Refractory Autoimmune Diseases
Phase: PHASE1

Find a Study Location Near You

This study is available at 28 research sites. We'll help you connect with the location that's right for you.

Participating sites include:
  • • Boston, Massachusetts
  • • Durham, North Carolina
  • • Camperdown, New South Wales
  • • And 25 more locations - let us help you find the closest one

Loading interactive enrollment tools...

The full interactive experience will load momentarily

A Study of Healthy Donor CD19-targeted Allogeneic CAR T Cells in Participants With Severe, Refractory Autoimmune Diseases - Join Clinical Trial NCTNCT07115745

How to Join This Clinical Trial - NCTNCT07115745

Learn how to participate in this PHASE1 trial studying an investigational therapy for Refractory Autoimmune Diseases. This study is currently enrolling participants.

Am I Eligible for This Clinical Trial?

This clinical research study is looking for participants with Refractory Autoimmune Diseases. Eligibility requirements include specific age ranges, health status, and medical history. Contact the study team to learn if you qualify.

Condition Being Studied
Refractory Autoimmune Diseases
Treatment Being Tested
Investigational treatment
Study Phase
PHASE1 - Early safety study
Enrollment Status
Currently enrolling participants
Study Identifier
NCTNCT07115745 - ClinicalTrials.gov Identifier
Sponsored By
Study sponsor

What to Expect as a Participant

Participating in this clinical trial involves:

  • Initial screening to determine eligibility
  • Regular study visits and health assessments
  • Receiving the study treatment or placebo
  • Medical monitoring and follow-up care
  • Contributing to medical research that may help others
  • Potential access to new treatments before they're widely available

Clinical Trial Benefits and Compensation

Participants in this clinical research study may receive:

  • Close medical monitoring by healthcare professionals
  • Access to potential new treatments
  • Compensation for time and travel (varies by study)
  • No-cost study-related medical care
  • The opportunity to help advance medical knowledge

Where Is This Clinical Trial Located?

This study is enrolling participants at 28 locations. Find a study site near you:

Clinical Research Site

Boston, Massachusetts 02115 - United States

Status: RECRUITING

Clinical Research Site

Durham, North Carolina 27705-2771 - United States

Status: RECRUITING

Clinical Research Site

Camperdown, New South Wales 2050 - Australia

Status: NOT_YET_RECRUITING

Clinical Research Site

Brisbane, Queensland 4029 - Australia

Status: WITHDRAWN

Clinical Research Site

Clayton, Victoria 3168 - Australia

Status: NOT_YET_RECRUITING

Clinical Research Site

Salvador, Estado de Bahia 41253-190 - Brazil

Status: NOT_YET_RECRUITING

Clinical Research Site

Porto Alegre, 0 - Brazil

Status: NOT_YET_RECRUITING

Clinical Research Site

São Paulo, 01508-010 - Brazil

Status: NOT_YET_RECRUITING

Clinical Research Site

Prague, Praha 5 150 06 - Czechia

Status: NOT_YET_RECRUITING

Clinical Research Site

Prague, 12850 - Czechia

Status: RECRUITING

And 18 more locations available. Contact us to find the nearest participating site.

How to Enroll in This Study

To learn more about participating in this PHASE1 clinical trial for Refractory Autoimmune Diseases:

  1. Review the eligibility criteria with your healthcare provider
  2. Contact the study team for a pre-screening interview
  3. Schedule an in-person screening visit if eligible
  4. Review and sign the informed consent form
  5. Begin participation in the clinical trial

Why Choose Quri.ai as Your Clinical Trial Matching Service

Quri.ai is a free clinical trial matching service that helps patients connect with research sites. We make it easier to:

  • Find clinical trials that match your condition
  • Get matched to the right study location near you
  • Connect directly with study coordinators
  • Understand if you qualify with simplified eligibility screening
  • Navigate the enrollment process with personalized support
  • Access new treatments through clinical research participation